ArticleCancer research communications2026

ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy.

Po-Han Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.